Proliferative marker Ki-67 in gallbladder carcinomas: High expression level predicts early recurrence after surgical resection

Cancer Letters

Volumn 176, Issue 2, 2002, Pages 191-198

  Hui, Ai Min ^b   Shi, Ya Zhou ^a   Li, Xin ^a   Sun, Lin ^a   Guido, Torzilli ^a   Takayama, Tadatoshi ^a   Makuuchi, Masatoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Gallbladder cancer; Prognosis; Proliferation

Indexed keywords

KI 67 ANTIGEN; TUMOR MARKER;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GALLBLADDER CARCINOMA; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; PREDICTION; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; CARCINOMA; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; TIME FACTORS;

EID: 0037169866     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(01)00749-2     Document Type: Article

References (33)

1. Ki-67 staining as a means to simplify analysis of tumor cell proliferation
2. Little missed markers and Ki-67
3. Which proliferation markers for routine immunohistology? A comparison of five antibodies
4. Abnormal cell cycle regulation in malignancy
5. The Ki-67 protein: From the known and the unknown
6. Ki-67 immunostaining in human breast tumors and its relationship to prognosis
7. Proliferative activity is a significant prognostic factor in male breast carcinoma
8. Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: Associations with other prognostic factors and survival
9. Prognostic significance of the MIB-1 proliferation index for patients with squamous cell carcinoma of the esophagus
10. Prognostic implication of proliferative markers MIB-1 and PC10 in esophageal squamous cell carcinoma
11. Prognostic significance of Ki67 labelling in resected non small cell lung cancer
12. Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67
13. Prognostic significance of Ki67 (MIB1) proliferation index and p53 over-expression in chondrosarcomas
14. Prognostic implications of p53 nuclear overexpression and high proliferation index of Ki-67 in adult soft-tissue sarcomas
15. Prognostic relevance of p53 alterations and Mib-1 proliferation index in subgroups of primary liposarcomas
16. Ki-67-determined growth fraction versus standard staging and grading parameters in colorectal carcinoma: A multivariate analysis
17. Determination of proliferative activity in colorectal carcinoma using monoclonal antibody Ki 67
18. Ki-67 immunoreactivity, ploidy and S-phase fraction as prognostic factors in patients with gastric carcinoma
19. Clinical relevance of p53 index and expression of proliferating cell nuclear antigen and Ki-67 in gastric cancer
20. Study on Ki-67 immunoreactivity as a prognostic indicator in patients with advanced gastric cancer
21. Carcinoma of the ampulla of Vater: Prognostic factors after curative surgery: A series of 45 cases
22. Proliferation markers Ki67 and PCNA in cutaneous squamous cell carcinomas: Lack of prognostic value
23. Ki67 labelling index correlates with stage and histology but not significantly with prognosis in thymoma
24. Prognostic significance of Ki67, p53, and epidermal growth factor receptor immunostaining in human glioblastomas
25. Kip1 expression in normal epithelia, precancerous lesions and carcinomas of the gall-bladder: Association with cancer progression and prognosis
26. Over-expression and lack of retinoblastoma protein are associated with tumor progression and metastasis in hepatocellular carcinoma
27. Prognostic significance of Ki-67 and p53 antigen expression in carcinomas of bile duct and gallbladder
28. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas
29. The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas
30. Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma
31. p53 and Ki-67 immunoreactivity and nuclear morphometery of 'carcinoma-in-adenoma' and adenoma of the gall-bladder